Role of inorganic nanoparticle degradation in cancer therapy
Open Access
- 27 July 2020
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Nanoscale Advances
- Vol. 2 (9) , 3734-3763
Abstract
Nanomaterials are currently widely exploited for their potential in the development of novel cancer therapies, and so far, mainly nanoparticles (NPs) consisting of liposomes and polymers have made their way into the clinic. However, major bottlenecks for the clinical translation of other types of NPs (i.e. inorganic) are the lack of knowledge concerning their long-term distribution in vivo and their potential toxicity. To counter this, various research groups have worked on soluble NPs, such as zinc oxide (ZnO), copper oxide (CuO), and silver (Ag), which tend to dissolve spontaneously into their ionic form, releasing toxic metal ions and leading to reactive oxygen species (ROS) generation when exposed to cellular environments. By fine-tuning the dissolution kinetics of these NPs, it is possible to control the level of ROS production and thus cytotoxicity to selectively destroy tumor tissue. Specifically, cancer cells tend to exhibit a higher basal level of oxidative stress compared to normal cells due to their higher metabolic rates, and therefore, by engineering NPs that generate sufficient ROS that barely exceed toxic thresholds in cancer cells, normal cells will only experience reversible transient damage. This review focuses on the use of these soluble inorganic NPs for selective cancer therapy and on the various in vitro and in vivo studies that have aimed to control the dissolution kinetics of these NPs, either through particle doping or surface modifications.Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (G0B2919N)
- H2020 European Research Council (757398)
- Bijzonder Onderzoeksfonds (3M180306)
This publication has 195 references indexed in Scilit:
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signalingCellular Signalling, 2012
- Signal Transduction by Mitochondrial OxidantsJournal of Biological Chemistry, 2012
- Anti-proliferative activity of silver nanoparticlesBMC Cell Biology, 2009
- Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cellsToxicology in Vitro, 2009
- Autophagy fights disease through cellular self-digestionNature, 2008
- Lysosomes in iron metabolism, ageing and apoptosisHistochemistry and Cell Biology, 2008
- Hydrogen Peroxide Triggered Prochelator Activation, Subsequent Metal Chelation, and Attenuation of the Fenton ReactionAngewandte Chemie International Edition, 2007
- Nucleation of protein fibrillation by nanoparticlesProceedings of the National Academy of Sciences, 2007
- Zinc transporter 2 (SLC30A2) can suppress the vesicular zinc defect of adaptor protein 3-depleted fibroblasts by promoting zinc accumulation in lysosomesExperimental Cell Research, 2007
- Reactive Species and Antioxidants. Redox Biology Is a Fundamental Theme of Aerobic LifePlant Physiology, 2006